状細胞病の治療薬の開発
1Laboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, and Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
まとめ
新種のエピジェネティック・モディファイヤーは 胎児のヘモグロビンのレベルを高めることで 臨床前の研究で有望であることが示されました この発見は,血液疾患の新たな治療戦略につながるかもしれません.
科学分野:
- エピジェネティクス
- 血液学
- 分子生物学
背景:
- 胎児のヘモグロビン (HbF) は酸素輸送において重要な役割を果たします.
- 減少したHbFレベルは,状細胞病やβ-タラセミアなどの様々なヘモグロビノパシーと関連しています.
- HbFを増加させる戦略は,これらの状態の重要な治療目標です.
研究 の 目的:
- 新しく特定された表遺伝子変異体の役割を調査する.
- 胎児のヘモグロビン分泌を増やす可能性を 調べるため
主な方法:
- エピジェネティック・モディファイヤーの効果を評価するために,臨床前モデルを使用した.
- 胎児のヘモグロビンレベルを測定するために分子および細胞測定を行った.
主要な成果:
- 新規のエピジェネティック・モディファイヤーは,臨床前試験で胎児のヘモグロビン発現を有意に増加させた.
- 作用のメカニズムは特定の表遺伝子経路の調節を伴う.
結論:
- この新発見のエピジェネティック・モディファイヤーは 治療の標的となる可能性があります
- ヘモグロビノパシーに対する臨床的適用性を調べるためにさらなる研究が必要である.
さらに関連する動画
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.5K
関連する概念動画
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
323
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
323
